Patent · US Active

Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor

US8030321B2 · kind B2 · utility

1Cited by

8References

14Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Frank Chavez · San Diego, US
Michael P. Curtis · Portage, US
James P. Edwards · San Diego, US
Laurent Gomez · San Diego, US
Cheryl A. Grice · Carlsbad, US
Aaron M. Kearney · Lakeside, US
Brad M. Savall · San Diego, US

Key dates

Filing date	Jul 2, 2009
Grant date	Oct 4, 2011
Priority date	—
Expiry date	Apr 12, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Benzofuro- and benzothienopyrimidine compounds are described, which are useful as H4 receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H4 receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.